期刊文献+

2%夫西地酸乳膏治疗细菌感染性皮肤病疗效与安全性观察 被引量:18

Clinical effect and safety of 2% fusidic acid cream for the treatment of bacterial skin infections
原文传递
导出
摘要 目的探讨夫西地酸乳膏治疗细菌感染性皮肤病的临床效果及安全性,为临床诊治提供参考依据。方法选择2012年1月-2015年1月90例细菌感染性皮肤病患者,按照治疗方法分为对照组与观察组,对照组40例患者使用2%莫匹罗星软膏治疗,观察组50例患者使用2%夫西地酸乳膏治疗;对比两组患者的治疗有效率及不良反应,数据采用SPSS 21.0软件进行统计分析。结果观察组与对照组治疗后相比治疗前症状EASI评分、瘙痒评分对比差异均有明显改善,对比差异有统计学意义(P<0.05);观察组治疗有效率为96.0%、对照组为92.5%,差异无统计学意义;对照组出现皮肤瘙痒及局部灼热感各1例,观察组出现1例局部灼热感,均未作特殊处理,自行缓解,两组不良反应对比差异无统计学意义。结论 2%夫西地酸乳膏治疗细菌感染性皮肤病临床效果好,利于缓解患者症状,值得临床推广应用。 OBJECTIVE To investigate clinical effect and safety of 2%fusidic acid cream for the treatment for bacterial skin infections,and to provide a reference for clinical treatment.METHODS From Jan.2012 to Jan.2015,90 patients with skin disorders caused by bacterial infections were selected,and they were divided into two groups according to treatment,that were observation group and control group.Control group(40patients)used 2% mupirocin ointment,and observation group(50patients)used 2%fusidic acid cream.Treatment efficiency rate and adverse reactions were compared between two groups.Data were analyzed with SPSS 21.0.RESULTS Both in observation group and control group,symptoms EASI scores before and after treatment,and itching scores showed significant improvement(P〈0.05);treatment efficiency rate of observation group was 96.0%,compared to control group 92.5%,the difference was not significant.There was 1case of skin itch and 1case of local burning sensation in control group,1case of local burning sensation in observation group,and the difference was not significant.CONCLUSION2%fusidic acid cream has good clinical effect for the treatment of bacterial skin infections,which will alleviate symptoms,and is worthy of clinical application.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2016年第7期1598-1600,共3页 Chinese Journal of Nosocomiology
基金 浙江省卫生厅基金资助项目(2013KYB230)
关键词 夫西地酸乳膏 细菌 感染性皮肤病 莫匹罗星软膏 瘙痒 Fusidic acid cream Bacteria Infections of the skin Mupirocin ointment Itch
  • 相关文献

参考文献3

二级参考文献66

  • 1Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 3554-3560.
  • 2Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yama- guchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.
  • 3Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gas- tric carcinoma in Mongolian gerbils. Cancer Res 1998; 58: 4255-4259.
  • 4Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helico- bacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998; 115: 642-648.
  • 5Mutoh H, Sakurai S, Satoh K, Tamada K, Kita H, Osawa H, Tomiyama T, Sato Y, Yamamoto H, Isoda N, Yoshida T, Ido K, Sugano K. Development of gastric carcinoma from intes- tinal metaplasia in Cdx2-transgenic mice. Cancer Res 2004; 64: 7740-7747.
  • 6Marshall LF, Becker DP, Bowers SA, Cayard C, Eisenberg H, Gross CR, Grossman RG, Jane JA, Kunitz SC, Rimel R, Tabaddor K, Warren J. The National Traumatic Coma Data Bank. Part 1: Design, purpose, goals, and results. J Neuro- surg 1983; 59: 276-284.
  • 7Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 2009; 119: 2475-2487.
  • 8Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Im- munologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various auto- immune diseases. J Immunol 1995; 155: 1151-1164.
  • 9Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD, Lechler RI. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 2001; 98: 2736-2744.
  • 10Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133: 775-787.

共引文献110

同被引文献108

引证文献18

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部